DiaMedica Therapeutics Inc. Company Profile
NASDAQ: DMACHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.99-0.14 (-1.72%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 7.99 0.00%
DiaMedica Therapeutics at a glance
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Minneapolis, MN. The company's shares have traded publicly since 2018. At a market capitalization of $438.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001401040, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- DiaMedica Therapeutics Inc.
- Ticker
- NASDAQ: DMAC
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- 301 Carlson Parkway, Suite 210 55305, Minneapolis, MN, United States
- Phone
- (763) 496-5454
- IPO year
- 2018
- Market cap
- $438.42M
- SEC CIK
- 0001401040
- Latest annual report
- 10-K · Mar 30, 2026
Companies similar to DiaMedica Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PRTAProthena Corporation plc | 8.48 | +5.74% | $435.34M | vs DMAC |
| SPRYARS Pharmaceuticals Inc. | 4.36 | +1.51% | $433.59M | vs DMAC |
| RZLTRezolute Inc. | 4.38 | +1.39% | $423.64M | vs DMAC |
| KMDAKamada Ltd. | 7.89 | -2.71% | $455.33M | vs DMAC |
| OVIDOvid Therapeutics Inc. | 2.36 | -0.42% | $460.90M | vs DMAC |
| ASMBAssembly Biosciences Inc. | 22.95 | +3.47% | $467.28M | vs DMAC |
| CAPRCapricor Therapeutics Inc. | 8.10 | +4.52% | $470.93M | vs DMAC |
| AVIRAtea Pharmaceuticals Inc. | 5.01 | -1.18% | $401.83M | vs DMAC |